 Lisa Ku
Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomyopathy, Dilated | 6 | 2007 | 381 | 0.420 |
Why?
| | Genetic Counseling | 2 | 2008 | 72 | 0.280 |
Why?
| | Genetics, Medical | 1 | 2006 | 24 | 0.270 |
Why?
| | Genetic Diseases, Inborn | 1 | 2006 | 38 | 0.260 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2021 | 25 | 0.180 |
Why?
| | Ascites | 1 | 2021 | 44 | 0.180 |
Why?
| | Ovarian Neoplasms | 2 | 2021 | 490 | 0.170 |
Why?
| | Precision Medicine | 1 | 2024 | 387 | 0.170 |
Why?
| | Genetic Predisposition to Disease | 3 | 2008 | 2282 | 0.160 |
Why?
| | Mutation, Missense | 3 | 2005 | 317 | 0.160 |
Why?
| | Glycogen Storage Disease Type IIb | 2 | 2007 | 25 | 0.130 |
Why?
| | Genetic Testing | 4 | 2021 | 428 | 0.120 |
Why?
| | Pedigree | 5 | 2007 | 487 | 0.110 |
Why?
| | Genes, Dominant | 3 | 2007 | 92 | 0.090 |
Why?
| | Consumer Health Information | 1 | 2008 | 49 | 0.070 |
Why?
| | Desmin | 1 | 2007 | 24 | 0.070 |
Why?
| | Retinitis Pigmentosa | 1 | 2006 | 20 | 0.070 |
Why?
| | BRCA1 Protein | 2 | 2021 | 65 | 0.060 |
Why?
| | Myopia | 1 | 2006 | 47 | 0.060 |
Why?
| | Risk | 2 | 2008 | 854 | 0.060 |
Why?
| | Ventricular Myosins | 1 | 2005 | 36 | 0.060 |
Why?
| | Physicians, Family | 1 | 2006 | 207 | 0.060 |
Why?
| | Age of Onset | 1 | 2006 | 496 | 0.060 |
Why?
| | Sodium Channels | 1 | 2004 | 63 | 0.060 |
Why?
| | Myosin Heavy Chains | 1 | 2005 | 170 | 0.060 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2005 | 132 | 0.060 |
Why?
| | Point Mutation | 1 | 2004 | 225 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2004 | 282 | 0.050 |
Why?
| | Cataract | 1 | 2006 | 208 | 0.050 |
Why?
| | Biological Specimen Banks | 1 | 2024 | 98 | 0.050 |
Why?
| | Mutation | 3 | 2008 | 3717 | 0.050 |
Why?
| | Arrhythmias, Cardiac | 1 | 2004 | 317 | 0.050 |
Why?
| | Referral and Consultation | 1 | 2006 | 732 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2021 | 84 | 0.040 |
Why?
| | BRCA2 Protein | 1 | 2021 | 53 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2021 | 140 | 0.040 |
Why?
| | Gene Frequency | 1 | 2021 | 503 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2005 | 1119 | 0.040 |
Why?
| | Practice Guidelines as Topic | 1 | 2006 | 1501 | 0.040 |
Why?
| | Genomics | 1 | 2024 | 716 | 0.040 |
Why?
| | Pediatrics | 1 | 2006 | 1052 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2005 | 1443 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2006 | 1279 | 0.040 |
Why?
| | Colorado | 2 | 2024 | 4421 | 0.040 |
Why?
| | Sequence Analysis, DNA | 1 | 2021 | 779 | 0.040 |
Why?
| | Humans | 11 | 2024 | 129650 | 0.030 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 2 | 2007 | 28 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2021 | 511 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2008 | 2142 | 0.030 |
Why?
| | Female | 9 | 2021 | 68776 | 0.030 |
Why?
| | Heterozygote | 2 | 2005 | 272 | 0.030 |
Why?
| | Adult | 4 | 2008 | 35576 | 0.020 |
Why?
| | Male | 7 | 2007 | 63681 | 0.020 |
Why?
| | Middle Aged | 4 | 2021 | 31154 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 7086 | 0.020 |
Why?
| | Marketing of Health Services | 1 | 2008 | 14 | 0.020 |
Why?
| | Phenotype | 2 | 2007 | 3076 | 0.020 |
Why?
| | Women | 1 | 2008 | 52 | 0.020 |
Why?
| | Genetic Carrier Screening | 1 | 2007 | 26 | 0.020 |
Why?
| | Frameshift Mutation | 1 | 2006 | 32 | 0.020 |
Why?
| | Electroretinography | 1 | 2006 | 45 | 0.020 |
Why?
| | Pigment Epithelium of Eye | 1 | 2006 | 34 | 0.020 |
Why?
| | Aged | 2 | 2021 | 22103 | 0.020 |
Why?
| | Visual Fields | 1 | 2006 | 87 | 0.020 |
Why?
| | Lamin Type A | 1 | 2005 | 48 | 0.020 |
Why?
| | Fluorescein Angiography | 1 | 2006 | 143 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2007 | 400 | 0.020 |
Why?
| | Molecular Epidemiology | 1 | 2005 | 63 | 0.010 |
Why?
| | Sarcomeres | 1 | 2005 | 92 | 0.010 |
Why?
| | NAV1.5 Voltage-Gated Sodium Channel | 1 | 2004 | 12 | 0.010 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2004 | 48 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2005 | 227 | 0.010 |
Why?
| | Transfection | 1 | 2007 | 911 | 0.010 |
Why?
| | Family Health | 1 | 2005 | 198 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2005 | 387 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2005 | 391 | 0.010 |
Why?
| | HeLa Cells | 1 | 2005 | 608 | 0.010 |
Why?
| | Chromatography, Liquid | 1 | 2005 | 423 | 0.010 |
Why?
| | Exons | 1 | 2004 | 342 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2005 | 840 | 0.010 |
Why?
| | Haplotypes | 1 | 2004 | 475 | 0.010 |
Why?
| | Myocytes, Cardiac | 1 | 2007 | 499 | 0.010 |
Why?
| | Health Promotion | 1 | 2008 | 719 | 0.010 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2005 | 385 | 0.010 |
Why?
| | Gene Expression | 1 | 2007 | 1472 | 0.010 |
Why?
| | Myocardium | 1 | 2005 | 980 | 0.010 |
Why?
| | Prevalence | 1 | 2007 | 2564 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2007 | 4083 | 0.010 |
Why?
| | Registries | 1 | 2007 | 1896 | 0.010 |
Why?
| | Rats | 1 | 2007 | 5500 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2005 | 3381 | 0.010 |
Why?
| | Cohort Studies | 1 | 2007 | 5420 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 1614 | 0.010 |
Why?
| | Infant | 1 | 2007 | 9024 | 0.010 |
Why?
| | Heart Failure | 1 | 2005 | 2150 | 0.010 |
Why?
| | United States | 1 | 2007 | 13903 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2006 | 14518 | 0.000 |
Why?
| | Adolescent | 1 | 2007 | 20393 | 0.000 |
Why?
| | Animals | 1 | 2007 | 35361 | 0.000 |
Why?
|
|
Ku's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|